Abstract
The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure-monitoring feature. A randomized controlled trial. Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without a blood pressure-monitoring feature for 12weeks. Data were collected using Omron HEM-907, Inbody 270S, and the International Physical Activity Questionnaire. Results revealed a significant effect and group-by-time interaction on diastolic blood pressure. After 12weeks in participants who wore a smartwatch with a blood pressure-monitoring feature, the systolic and diastolic blood pressure and resting heart rate had decreased. Using commercial smartwatches with a blood pressure-monitoring feature is a feasible approach to support self-management, increase awareness, and promote physical activity for health promotion, obesity and chronic disease prevention. Wearable technologies may be an innovative strategy for preventing high blood pressure by continuous self-monitoring and healthy behavior modifications.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
